Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01263821 · ClinicalTrials.gov registry record · NA
Image Guided Therapy in the Treatment of Gliomas
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01263821 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 15 participants.
The verdict
NCT01263821, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
RATIONALE: New imaging techniques using magnetic resonance imaging give better tumor definition, thus may lead to better tumor targeting and avoid damaging critical parts of normal brain. PURPOSE: This phase I/II trial is studying how well image-guided therapy works in treating patients with newly diagnosed intracranial glioma.
Interventions
- PROCEDURE Functional magnetic resonance imaging
- PROCEDURE Diffusion-weighted magnetic resonance imaging
- PROCEDURE Therapeutic conventional surgery
- PROCEDURE Perfusion-weighted magnetic resonance imaging
- PROCEDURE Magnetic resonance spectroscopic imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-08 |
| Est. Completion | 2014-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01263821
The ClinicalTrials.gov registry entry for NCT01263821 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Functional magnetic resonance imaging is the first listed.
NCT01263821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01263821 about?
NCT01263821 is a clinical study titled "Image Guided Therapy in the Treatment of Gliomas". RATIONALE: New imaging techniques using magnetic resonance imaging give better tumor definition, thus may lead to better tumor targeting and avoid damaging critical parts of normal brain. PURPOSE: This phase I/II trial is studying how well image-guided therapy works in treating patients with newly ...
What is the current status of trial NCT01263821?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2009-08. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01263821?
The interventions under investigation include: Functional magnetic resonance imaging (PROCEDURE), Diffusion-weighted magnetic resonance imaging (PROCEDURE), Therapeutic conventional surgery (PROCEDURE), Perfusion-weighted magnetic resonance imaging (PROCEDURE), Magnetic resonance spectroscopic imaging (PROCEDURE).
Who is sponsoring clinical trial NCT01263821?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.